Article in Genes, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors at 2 institutions in 1 country.
Liliya SkvortsovaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.ORCID 0000-0002-2035-2244
Saltanat AbdikerimLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.
Kanagat YergaliLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.
Natalya MitLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.
Anastassiya PerfilyevaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.
Nazgul OmarbayevaBreast Cancer Department, Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan.
Aigul ZhunussovaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.
Zulfiya KachiyevaResearch Institute of Applied and Fundamental Medicine, Asfendiyarov Kazakh National Medical University, Almaty 050012, Kazakhstan.ORCID 0000-0002-3732-3546
Tolkyn SadykovaBreast Cancer Department, Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan.
Bakhytzhan BekmanovLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.ORCID 0000-0002-2232-0481
Dilyara KaidarovaBreast Cancer Department, Kazakh Institute of Oncology and Radiology, Almaty 050060, Kazakhstan.
Leyla DjansugurovaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.ORCID 0000-0002-6745-9903
Gulnur ZhunussovaLaboratory of Molecular Genetics, Institute of Genetics and Physiology, Almaty 050060, Kazakhstan.ORCID 0000-0001-8642-9577
Kazakh National Medical University · KZAl-Farabi Kazakh National University · KZ
Funding
Ministry of Healthcare of the Republic of Kazakhstan 49019/ПЦФ-МЗСР-ОТ-18Ministry of Healthcare of the Republic of Kazakhstan OR12165486Ministry of Science and Higher Education of the Republic of Kazakhstan AP09259034
6 · The paper itself
Abstract
Breast cancer is a global health problem. It is an age-dependent disease, but cases of early-onset breast cancer (eBC) are gradually increasing. There are many unresolved questions regarding eBC risk factors, mechanisms of development and screening. Only 10% of eBC cases are due to mutations in the
Indexed as
Breast NeoplasmsChitinasesExonsFemaleGenetic BackgroundGenetic MarkersGenome-Wide Association StudyHumansCHI3L2 protein, humanChitinasesGenetic Markersearly-onset breast cancergenetic markersgenetic variationsgenome-wide association studyKazakh populationmicroarray-based SNP genotyping
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Association of Genetic Markers with the Risk of Early-Onset Breast Cancer in Kazakh Women. · full record | OpenQuestion